GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioInfra Life Science Inc (XKRX:266470) » Definitions » Research & Development

BioInfra Life Science (XKRX:266470) Research & Development : ₩247.5 Mil (TTM As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is BioInfra Life Science Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. BioInfra Life Science's Research & Development for the six months ended in Dec. 2024 was ₩247.5 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was ₩247.5 Mil.


BioInfra Life Science Research & Development Historical Data

The historical data trend for BioInfra Life Science's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioInfra Life Science Research & Development Chart

BioInfra Life Science Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only 1,120.08 911.16 994.52 999.81 247.53

BioInfra Life Science Semi-Annual Data
Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only 1,120.08 911.16 994.52 999.81 247.53

BioInfra Life Science Research & Development Calculation

This is the expense the company spent on research and development.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was ₩247.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioInfra Life Science  (XKRX:266470) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


BioInfra Life Science Research & Development Related Terms

Thank you for viewing the detailed overview of BioInfra Life Science's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


BioInfra Life Science Business Description

Traded in Other Exchanges
N/A
Address
Daehak-ro 49, 7th Floor, Jongno-gu, Seoul, KOR, 03127
BioInfra Life Science Inc is a bio-technology company engaged in developing cancer gene treatments and technologies that systematically monitor the possibility of metastasis and recurrence in blood for cancer patients.

BioInfra Life Science Headlines

No Headlines